Clinical Trials Browser

Phase 2 × Recurrence × glumetinib × Clear all

NCT06525350 2024-07-29

A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

Recurrence